Migraine Trial, Recruiting NCT05943457 Sponsor: Sola Aoun Bahous, M.D. Ph.D. Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT05943457
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with episodic migraine (with or without aura) for more than 12 months, based on recognised international headache guidelines
  • You experienced migraines on 4 to 14 days per month in the 3 months before the screening visit
  • You experienced migraines on 4 to 14 days per month during the initial assessment/monitoring period
  • You successfully completed a migraine diary during the initial monitoring period

Who may not be able to join:

  • You have migraines alongside tension-type headaches or other types of primary headaches
  • You are currently taking any of the following migraine prevention medications: sodium valproate, topiramate, beta-blockers, tricyclic antidepressants, SNRIs, flunarizine, verapamil, lisinopril, or candesartan
  • You have taken any of those listed prevention medications within the past 3 months
  • You take ergotamine or triptan medications more than 10 days per month
  • You take anti-inflammatory painkillers (NSAIDs) or paracetamol more than 15 days per month
  • You take opioid (strong) painkillers more than 4 days per month
  • You take blood-thinning (anticoagulant) medications
  • You have another ongoing long-term pain condition, such as fibromyalgia or nerve pain (confirm with trial site)
  • You have a known allergy or sensitivity to Vitamin K2
  • You have a known allergy to soy protein, cheese, eggs, or meat
  • You have a history of blood clots (thrombotic events)
  • You have a diagnosed blood clotting disorder or any related condition
  • You have had a heart or cardiovascular event in the past month
  • You are currently pregnant or planning to become pregnant
  • You are currently breastfeeding
  • You are unable to swallow or take oral (by mouth) medications
  • You have a known condition affecting how your intestines absorb or move food/medications (confirm with trial site)
  • You have atrial fibrillation (an irregular heart rhythm condition)
  • You have an active cancer diagnosis
  • You have had any acute (sudden/short-term) illness in the past month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sola Aoun Bahous, MD, PhD, Lebanese American University School of Medicine

Phone: +9613259450

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sola Aoun Bahous, M.D. Ph.D.
Registry
ClinicalTrials.gov
Start date
6 March 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇱🇧 Lebanon

Primary endpoints

Changes of monthly migraine days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov